You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aggressive highly active multiple sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Silent Progression Activity Monitoring - SPAM Study

Not yet recruiting
  • Multiple Sclerosis
  • NO INTERVENTION
  • Nice, France
    CHU de Nice
Dec 5, 2022

Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
    • Coventry, United Kingdom
    • +7 more
    May 20, 2022

    Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

    Not yet recruiting
    • Relapsing-remitting Multiple Sclerosis
    • CT-P53
    • +2 more
    • (no location specified)
    Jun 7, 2023

    Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

    Recruiting
    • Multiple Sclerosis, Secondary Progressive
    • Multiple Sclerosis
    • Cladribine Subcutaneous Injection
    • 0.9% Chloride Injection Sodium
    • Warsaw, Mazowieckie, Poland
      Institute of Psychiatry and Neurology
    Jul 26, 2023

    Multiple Sclerosis Trial in New York (Active tDCS, Sham () stimulation)

    Recruiting
    • Multiple Sclerosis
    • Active tDCS
    • Sham (placebo) stimulation
    • New York, New York
      New York University School of Medicine
    Dec 28, 2022

    Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

    Not yet recruiting
    • Relapsing Forms of Multiple Sclerosis
    • (no location specified)
    Mar 23, 2023

    Multiple Sclerosis Trial (Siponimod)

    Available
    • Multiple Sclerosis
    • (no location specified)
    Sep 13, 2022

    Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

    Recruiting
    • Secondary-progressive Multiple Sclerosis
    • Buffalo, New York
      University at Buffalo, Buffalo General Hospital
    Oct 10, 2022

    Multiple Sclerosis Trial (Ocrelizumab Injection [Ocrevus])

    Not yet recruiting
    • Multiple Sclerosis
    • Ocrelizumab Injection [Ocrevus]
    • (no location specified)
    Aug 22, 2023

    Multiple Sclerosis Trial in New York (active tDCS, sham tDCS, Physical Activity (PA))

    Recruiting
    • Multiple Sclerosis
    • active tDCS
    • +2 more
    • New York, New York
      New York University School of Medicine
    Aug 5, 2022

    Measuring Active Microglia in Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
    • [C11]PK-1195 PET scan
    • New York, New York
      Weill Cornell Medical College
    Jan 14, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Early Aggressive Therapy or Traditional Therapy
    • Birmingham, Alabama
    • +51 more
    Jan 23, 2023

    Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

    Recruiting
    • Progressive Multiple Sclerosis
    • Placebo
    • Masitinib (4.5)
    • Lille, France
    • +1 more
    Jul 1, 2022

    Multiple Sclerosis Trial in Moscow (BCD-132, Teriflunomide)

    Recruiting
    • Multiple Sclerosis
    • Moscow, Russian Federation
      State Budgetary Healthcare Institution of the Moscow Region M.F.
    May 18, 2022

    Multiple Sclerosis Trial in Worldwide (Mavenclad®)

    Completed
    Has Results
    • Multiple Sclerosis
    • Sydney, New South Wales, Australia
    • +53 more
    Jul 25, 2022

    Multiple Sclerosis Trial in France (Clinical assessment, Classical cognitive evaluation of several domains:, Ecological

    Not yet recruiting
    • Multiple Sclerosis
    • Clinical assessment
    • +5 more
    • Bordeaux, France
    • +6 more
    Nov 3, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Glostrup, Copenhagen, Denmark
    • +11 more
    May 3, 2022

    Pediatric Multiple Sclerosis Trial in Birmingham, Philadelphia, Toronto (Physical Activity (PA) Intervention, Waitlist

    Recruiting
    • Pediatric Multiple Sclerosis
    • Physical Activity (PA) Intervention
    • Waitlist attention-control
    • Birmingham, Alabama
    • +2 more
    Mar 15, 2022

    Multiple Sclerosis, Spasticity, Muscle, Pain, Chronic Trial (FlowOx 2.0, FlowOx2.0 (Sham))

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • FlowOx 2.0
    • FlowOx2.0 (Sham)
    • (no location specified)
    Sep 28, 2022

    Pediatric Onset Multiple Sclerosis (POMS) Trial in Houston (VR active video game intervention, Educational session, Standard

    Terminated
    Has Results
    • Pediatric Onset Multiple Sclerosis (POMS)
    • VR active video game intervention
    • +2 more
    • Houston, Texas
      The University of Texas Health Science Center,Houston
    May 17, 2022

    Multiple Sclerosis Trial in Latham (Cladribine Tablets)

    Recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Latham, New York
      Multiple Sclerosis Center of Northeastern New York, P.C.
    Jan 12, 2022

    Multiple Sclerosis Trial in New York (Active tDCS, sham tDCS)

    Completed
    • Multiple Sclerosis
    • Active tDCS
    • sham tDCS
    • New York, New York
      NYU Langone Health
    Dec 1, 2021

    Multiple Sclerosis Trial in New York (Active tDCS)

    Recruiting
    • Multiple Sclerosis
    • Active tDCS
    • New York, New York
      NYU Langone Health
    Sep 13, 2022

    Multiple Sclerosis Trial in New York (Active RS-tDCS +At-Home Manual Dexterity Training, Sham RS-tDCS +At-Home Manual Dexterity

    Completed
    Has Results
    • Multiple Sclerosis
    • Active RS-tDCS +At-Home Manual Dexterity Training
    • +2 more
    • New York, New York
      New York University School of Medicine
    Feb 11, 2022

    Magnetic Resonance Imaging, CNS, Brain Trial in Paris (Additional MRI sequences)

    Completed
    • Magnetic Resonance Imaging
    • +4 more
    • Additional MRI sequences
    • Paris, France
      Fondation Ophtalmologique A. de Rothschild
    Sep 16, 2021